Marine (Laboratoire Chemineau/Laboratoire de la Mer)
Paris Orléans invested in mezzanine debt alongside TCR Capital in the takeover of Laboratoire de la Mer by Laboratoire Chemineau, one of the leading European pharmaceutical manufacturers of liquid and semi liquid products (bottles, gels, ointments, sprays).
In 2008, the company generated revenues of nearly €45 million with a workforce of around 280 people.Laboratoire de la Mer is a marine biotechnology company and is the European leader in over-the-counter nasal and auricular healthcare products.
The merger of these two companies will generate synergies (manufacturing process and procurement) and enable them to combine their sales forces. Laboratoire de la Mer has strong expertise in export markets.
| AS AT 31 MARCH 2010 | |
|---|---|
| Amount invested: | €10.2 million |
| Estimated value: | €11.2 million |
